M24 logotipas

M24.lt

VaistaiMPPKompensavimasTLKAsistentas
PrisijungtiRegistruotis

/

ATC kodai

/

L01FF: Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors

ATC kodas

L01FF: Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors

L: Antinavikiniai vaistai ir imunomoduliatoriai»L01: Tisagenlekleucelas»L01F: Monoclonal antibodies and antibody drug conjugates»L01FF: Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors

Vaistiniai preparatai

17

Kompensuojami

10

Tiekimo sutrikimai

2

Pogrupiai

L01FF01: NivolumabasL01FF02: PembrolizumabasL01FF03: DurvalumabasL01FF04: AvelumabasL01FF05: AtezolizumabasL01FF06: CemiplimabasL01FF07: DostarlimabasL01FF08: ProlgolimabasL01FF09: TislelizumabasL01FF10: Retifanlimabas

Vaistiniai preparatai

Forma

Stiprumas

Veiklioji medžiaga

Gamintojas

Kompensuojami

Rūšiuoti pagal:

Bavencio

koncentratas infuziniam tirpalui

20 mg/ml

Avelumabas

Merck Europe B.V.
K
R

-

-
Bavencio, koncentratas infuziniam tirpalui, 20 mg/ml

Avelumabas, 20 mg/ml

Merck Europe B.V.
Kompensuojamas
Receptinis
-
IMFINZI

koncentratas infuziniam tirpalui

50 mg/ml

Durvalumabas

AstraZeneca AB
K
R

-

2 646,28 €
IMFINZI, koncentratas infuziniam tirpalui, 50 mg/ml

Durvalumabas, 50 mg/ml

AstraZeneca AB
Kompensuojamas
Receptinis
2 646,28 €
Keytruda

koncentratas infuziniam tirpalui

25 mg/ml

Pembrolizumabas

Merck Sharp & Dohme B.V.
K
R

-

3 765,58 €
Keytruda, koncentratas infuziniam tirpalui, 25 mg/ml

Pembrolizumabas, 25 mg/ml

Merck Sharp & Dohme B.V.
Kompensuojamas
Receptinis
3 765,58 €
KEYTRUDA

injekcinis tirpalas

395 mg

Pembrolizumabas

Merck Sharp & Dohme B.V.
K
R

-

7 522,05 €
KEYTRUDA, injekcinis tirpalas, 395 mg

Pembrolizumabas, 395 mg

Merck Sharp & Dohme B.V.
Kompensuojamas
Receptinis
7 522,05 €
KEYTRUDA

injekcinis tirpalas

790 mg

Pembrolizumabas

Merck Sharp & Dohme B.V.
K
R

-

15 010,65 €
KEYTRUDA, injekcinis tirpalas, 790 mg

Pembrolizumabas, 790 mg

Merck Sharp & Dohme B.V.
Kompensuojamas
Receptinis
15 010,65 €
Tecentriq

koncentratas infuziniam tirpalui

840 mg

Atezolizumabas

Roche Registration GmbH
K
R

-

-
Tecentriq, koncentratas infuziniam tirpalui, 840 mg

Atezolizumabas, 840 mg

Roche Registration GmbH
Kompensuojamas
Receptinis
-
Tecentriq

koncentratas infuziniam tirpalui

1200 mg

Atezolizumabas

Roche Registration GmbH
K
R

-

4 008,13 €
Tecentriq, koncentratas infuziniam tirpalui, 1200 mg

Atezolizumabas, 1200 mg

Roche Registration GmbH
Kompensuojamas
Receptinis
4 008,13 €
Tecentriq

injekcinis tirpalas

1875 mg

Atezolizumabas

Roche Registration GmbH
K
R

-

-
Tecentriq, injekcinis tirpalas, 1875 mg

Atezolizumabas, 1875 mg

Roche Registration GmbH
Kompensuojamas
Receptinis
-
LIBTAYO

koncentratas infuziniam tirpalui

350 mg

Cemiplimabas

Regeneron Ireland Designated Activity Co...
K
R
S
4 550,35 €
LIBTAYO, koncentratas infuziniam tirpalui, 350 mg

Cemiplimabas, 350 mg

Regeneron Ireland Designated Activity Co...
Kompensuojamas
Tiekimas sutrikęs
Receptinis
4 550,35 €
OPDIVO

koncentratas infuziniam tirpalui

10 mg/ml

Nivolumabas

Bristol-Myers Squibb Pharma EEIG
K
R

-

638,65 — 3 725,28 €
OPDIVO, koncentratas infuziniam tirpalui, 10 mg/ml

Nivolumabas, 10 mg/ml

Bristol-Myers Squibb Pharma EEIG
Kompensuojamas
Receptinis
638,65 — 3 725,28 €
Cejemly

koncentratas infuziniam tirpalui

600 mg

Sugemalimabas

CStone Pharmaceuticals Ireland Limited

-

R
S
-
Cejemly, koncentratas infuziniam tirpalui, 600 mg

Sugemalimabas, 600 mg

CStone Pharmaceuticals Ireland Limited
Netiekiama
Receptinis
-
HETRONIFLY

koncentratas infuziniam tirpalui

10 mg/ml

Serplulimabas

Accord Healthcare S.L.U.

-

R
S
-
HETRONIFLY, koncentratas infuziniam tirpalui, 10 mg/ml

Serplulimabas, 10 mg/ml

Accord Healthcare S.L.U.
Netiekiama
Receptinis
-
JEMPERLI

koncentratas infuziniam tirpalui

500 mg

Dostarlimabas

GlaxoSmithKline Trading Services Limited

-

R
S
-
JEMPERLI, koncentratas infuziniam tirpalui, 500 mg

Dostarlimabas, 500 mg

GlaxoSmithKline Trading Services Limited
Netiekiama
Receptinis
-
LOQTORZI

koncentratas infuziniam tirpalui

240 mg

Toripalimabas

Topalliance Biosciences Europe Limited

-

R
S
-
LOQTORZI, koncentratas infuziniam tirpalui, 240 mg

Toripalimabas, 240 mg

Topalliance Biosciences Europe Limited
Netiekiama
Receptinis
-
OPDIVO

injekcinis tirpalas

600 mg

Nivolumabas

Bristol-Myers Squibb/Pfizer EEIG

-

R
S
-
OPDIVO, injekcinis tirpalas, 600 mg

Nivolumabas, 600 mg

Bristol-Myers Squibb/Pfizer EEIG
Netiekiama
Receptinis
-
Tevimbra

koncentratas infuziniam tirpalui

100 mg

Tislelizumabas

BeOne Medicines Ireland Limited

-

R
S
-
Tevimbra, koncentratas infuziniam tirpalui, 100 mg

Tislelizumabas, 100 mg

BeOne Medicines Ireland Limited
Netiekiama
Receptinis
-
ZYNYZ

koncentratas infuziniam tirpalui

500 mg

Retifanlimabas

Incyte Biosciences Distribution B.V.

-

R
S
-
ZYNYZ, koncentratas infuziniam tirpalui, 500 mg

Retifanlimabas, 500 mg

Incyte Biosciences Distribution B.V.
Netiekiama
Receptinis
-